Penumbra (PEN) EBITDA Margin (2014 - 2026)
Penumbra's EBITDA Margin came in at 13.70% for Q3 2026, down 0.77 percentage points from 14.47% a year earlier but up 1.74 percentage points from the prior quarter.
Penumbra (PEN) EBITDA Margin (2014 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Penumbra reported EBITDA Margin of 13.42%, down 0.84 percentage points year-over-year; for FY2025, it came in at 14.73%, up 11.97 percentage points from FY2024.
- EBITDA Margin carries a five-year change of +19.38 percentage points (FY2020 to FY2025).
- Going back by year, EBITDA Margin was 2.76% in FY2024 (-6.76 pp), 9.52% in FY2023 (+5.93 pp), 3.59% in FY2022 (+2.40 pp) and 1.19% in FY2021 (+5.84 pp).
- The five-year range for quarterly EBITDA Margin is -24.49% (Q2 2024) to 16.53% (Q4 2025).
- Year-over-year, EBITDA Margin has declined for three consecutive quarters, with an average year-over-year change of +5.39 percentage points over the last eight quarters.
- The fastest year-over-year change in EBITDA Margin over five years came in Q2 2025 (a gain of 38.14 percentage points), and the weakest in Q2 2024 (a drop of 33.89 percentage points).
- Business Quant data shows PEN's EBITDA Margin at 11.96% (Q2 2026), 11.42% (Q1 2026) and 16.53% (Q4 2025) in the three quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 266.22 Bn | 242.86 Bn | 5.13 Bn | 25.44% |
| 2 | Abbott Laboratories | 191.31 Bn | 165.77 Bn | 7.39 Bn | 20.09% |
| 3 | Danaher | 166.16 Bn | 145.82 Bn | 3.84 Bn | 30.00% |
| 4 | Intuitive Surgical | 155.98 Bn | 136.40 Bn | 2.08 Bn | 25.90% |
| 5 | Medtronic | 130.05 Bn | 96.18 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 123.40 Bn | 109.59 Bn | 4.25 Bn | - |
| 7 | Boston Scientific | 64.81 Bn | 60.48 Bn | 3.43 Bn | 23.14% |
| 8 | Edwards Lifesciences | 59.87 Bn | 43.18 Bn | 1.35 Bn | 20.05% |
| 9 | Medline | 53.84 Bn | 50.96 Bn | 1.93 Bn | 9.79% |
| 10 | Penumbra | 12.67 Bn | 10.17 Bn | 280.30 Mn | 13.70% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 13.70% |
| Jun 30, 2026 | 11.96% |
| Mar 31, 2026 | 11.42% |
| Dec 31, 2025 | 16.53% |
| Sep 30, 2025 | 14.47% |
| Jun 30, 2025 | 13.65% |
| Mar 31, 2025 | 14.00% |
| Dec 31, 2024 | 14.95% |
| Sep 30, 2024 | 13.13% |
| Jun 30, 2024 | -24.49% |
| Mar 31, 2024 | 7.04% |
| Dec 31, 2023 | 14.78% |
| Sep 30, 2023 | 7.22% |
| Jun 30, 2023 | 9.41% |
| Mar 31, 2023 | 6.04% |
| Dec 31, 2022 | 5.10% |
| Sep 30, 2022 | 5.46% |
| Jun 30, 2022 | 2.78% |
| Mar 31, 2022 | 0.82% |
| Dec 31, 2021 | -16.81% |
Penumbra EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=PEN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "PEN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=PEN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();